Zhenglong Wang

机构：Weifang Medical University, Zunyi Medical University, Viva Biotech (China) · ORCID：0000-0002-4860-540X

发表论文 42 篇 · 总被引 1434 次 · h-index 17

代表论文

• CircUbe3a from M2 macrophage-derived small extracellular vesicles mediates myocardial fibrosis after acute myocardial infarction (2021 · Theranostics · 被引 146)
• Exosomal circHIPK3 Released from Hypoxia-Pretreated Cardiomyocytes Regulates Oxidative Damage in Cardiac Microvascular Endothelial Cells via the miR-29a/IGF-1 Pathway (2019 · Oxidative Medicine and Cellular Longevity · 被引 137)
• Bone marrow mesenchymal stem cell-derived exosomal miR-21 protects C-kit+ cardiac stem cells from oxidative injury through the PTEN/PI3K/Akt axis (2018 · PLoS ONE · 被引 105)
• Exosomal CircHIPK3 Released from Hypoxia-Induced Cardiomyocytes Regulates Cardiac Angiogenesis after Myocardial Infarction (2020 · Oxidative Medicine and Cellular Longevity · 被引 77)
• Development of a machine learning model to predict the risk of late cardiogenic shock in patients with ST-segment elevation myocardial infarction (2021 · Annals of Translational Medicine · 被引 44)
• Clinical Feature-Based Machine Learning Model for 1-Year Mortality Risk Prediction of ST-Segment Elevation Myocardial Infarction in Patients with Hyperuricemia: A Retrospective Study (2021 · Computational and Mathematical Methods in Medicine · 被引 41)